Jay D. Amsterdam and Leemon B. McHenry : The Paroxetine 352 Bipolar Study Revisited : Desconstruction of Corporate and Academic  Misconduct 

Samuel Gershon’s comments

        I have reread the Jay Amsterdam and Leemon McHenry material and Daniel Kanofsky’s (2020) comment thereon. The Paroxetine 352 document presented a marvellously clear and detailed account of skullduggery in regard to the manipulation and falsification of scientific data by academic faculty who have been referred to as “key opinion leaders,” supported by their academic titles. These individuals have been paid to provide their names as authors of this material to persuade readers of its value in regard to their prescribing habits to utilize the compounds propounded for their clinical use. This, in some cases, has involved some collusion with some journal editors. Amsterdam and McHenry’s document reads like a carefully researched and prepared judicial indictment. It may well be that this sort of activity may not be limited to those named individuals and therefore we need to consider what practitioners and the academic faculty need to do to insure the integrity of published data and also to demand highly responsible research standards from the editorial members of the journals in our field. We hope these disclosures will demand a higher level of integrity from authors and journals.

Reference:

Kanofsky D. Comment. Jay D. Amsterdam and Leemon B. McHenry: The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct. inhn.org.controversies. March 26, 2020.

August 6, 2020